Abstract
Excessive Zn but normal Cu and Mg in the staple food consumed by the people of Chandigarh (Union territory and capital of Punjab and Haryana States of India) has been considered to be the major risk factor for the prevalence of obesity (33.15%) and obesity-related diseases in this region. Therefore, in the present investigations, in obesity-related diseases, the status of these minerals was estimated in their tissues, including hair, nails, and blood serum and urine, and compared with those of normal subjects. They were grouped as: normal subjects in control Group A, middle-aged diabetics in Group DM, older diabetics in Group DO, and diabetics with osteoarthritis in Group D+ OA, osteoarthritis in Group OA and rheumatoid arthritis in Group RA, respectively. The results evaluated in the order as: hair Zn, group D+OA>DM>OA>A (control)>RA>DO (p < 0.001); hair Cu, group A (control)>DM>OA>D+OA>DO>RA (p < 0.001); hair Mg, group A (control)>DM>OA>D+OA>RA>DO (p < 0.001, 0.01); hair Mn, group A (control)>RA>OA>D-OA>DM>DO (p < 0.001); nail Zn, group DM>D+OA>OA>A (control)>RA>DO (p < 0.001, 0.05); nail Cu, group A (control)>OA>DM>D+OA>RA>DO (p < 0.001); nail Mg, group A (control)>OA>DM>DO>D+OA >RA (p < 0.001); nail Mn, group A (control) >RA>OA>D+OA>DM>DO (p < 0.01); urine Zn, group DO>DM>D+OA>A (control)>RA>OA (p < 0.01); urine Cu, group RA>D+OA>DO>OA> DM>A (control) (p<0.001); urine Mg, group RA>OA>D+OA>DO>DM>A (control; p < 0.001); urine Mn, group DO>DM>OA>D+OA>RA>A (control; p < 0.001), respectively. The analysis of the mineral status in serum of diabetics further showed their highly significant rise from lower mean age subgroup to higher mean age subgroup than their control counter parts (p < 0.001, 0.01, and 0.05) with coincident deficiencies of Cu, Mg, and Mn in their tissues. This study would be helpful considering the status of minerals in these obesity-related diseases depending on the choice of the food consumed to improve the quality of life and prognosis for the diseases.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Obesity epidemic is mainly responsible for the rising prevalence of metabolic syndrome-X and cardiovascular diseases [1] resulting in increased mortality especially if obesity begins at an early age in adolescents [2]. Obesity strongly correlates with traditional risk factors, such as diabetes, hypertension, and hyperlipidemia. When women aged 30–35 years were monitored for 14 years, the additional risk of developing non-insulin-dependent diabetes mellitus (NIDDM) for those who were obese was over 40 times greater than for women who remained slim [3]. Overweight is associated with a two to six-fold increase in risk of developing hypertension [4]. Overweight individuals are also further at increased risk of developing joint diseases leading to osteoarthritis (OA) and rheumatoid arthritis (RA) especially in the women [5–11].
The underline event in the obesity is the inflammation when it was discovered that inflammatory cytokines are overproduced in the adipose tissue and muscle tissues of obese humans due to overproduction of reactive oxygen species (ROS) [12–17]. Available data strongly suggest that inflammation is a primary cause of obesity-linked diseases such as NIDDM, hyperglycemia, hyperlipidemia, osteoarthritis, and rheumatoid arthritis rather than merely a consequence [18].
The prevalence of overweight/obesity in the Chandigarh population (Union territory of Panjab and Haryana of India) was reported as 33.15% (42.1% in women and 20.9% in men), and this prevalence of obesity has nearly become double among the urban population of Chandigarh in the last 30 years. The high prevalence of obesity in this region has led to an increase in hypertension as 82.5% among overweight elderly in comparison to 45.87% non-overweight elderly subjects [19]. It seems that dietary factors and activity patterns are more involved than any other factor in the etiology of the higher prevalence of hypertension in this region.
Many theories have been proposed to explain the mechanism involved in the devolvement of the obesity. Primary factors are dietary factors, and it was reported in our previous studies that the diets used in this region is rich in Zn content that has been reported to induce obesity [20, 21]. Kang [22] observed that the amount of fat deposition in tissues of mice depends on the amount of Zn present in diet, suggesting the importance of Zn/fat ratio as an essential criterion in the etiology of obesity. The proposed potential mechanisms for the development of obesity due to high Zn intake in the experimental animals have been already suggested [23, 24]. A higher intake of Zn results in an increase in subcutaneous fat in the animals and humans, and a possible factor favoring obesity has been suggested by many [25–28]. Leptin, a product of ob gene, is expressed mainly in adipose tissue and participates in diabetes and hypertension in obese individuals [29–35]. Leptin levels were directly correlated with the higher Zn supplementation in rats [35].
In the recent years, further, a number of studies have investigated the possible role of Zn, Cu, Mg, and Mn in the obesity, diabetes, osteoarthritis, and rheumatoid arthritis [36–42]. Higher Zn and Cu levels in the urine of diabetic patients were reported [43–46]. Diabetic humans have been reported to have hypo- [47], normo- [48–51], and hyperzincemia [44, 52, 53] as reported in obese [21]. The role of Zn and Cu in chronic inflammatory disease is of interest because they are co-factors of important enzymes involved in collagen and bone metabolism [54–57] and antioxidant protection [58]. Patients with rheumatoid arthritis were also found to have elevated urinary Cu excretion rates, but the Zn levels in serum and urine did not differ significantly from control [59]. Serum Zn and Cu levels were observed to decrease more in RA than OA [60]. Serum Mg and Mn were found to be non-significantly lower in RA than the control, but higher Cu and lower Zn were found in RA than control [61].
In the previous epidemiological studies in this region, higher Zn levels were observed in nails, hairs, and urine of obese and in the patients of diabetics and myocardial infarction with low Cu status than the normal subjects indicating Cu deficiency in these patients. This greater bioavailability of Zn in adults over a period of years as reflected in our previous study on Chandigarh population is significant enough to reflect the changes in body weight leading to obesity [21, 28, 62–68].
The rising prevalence of obesity and obesity-related disease during the past two decades in this region, therefore, may not essentially be due to the change in lifestyle but may also be associated with the excessive Zn intake through food chain [21]. To elucidate further the link between excessive Zn in diet and diabetes mellitus and joint diseases in the Chandigarh population, investigations were carried out on these patients, and the results of this study are reported in this paper.
Materials and Methods
Present study was conducted on the population residing in Chandigarh. It is the first well-planned modern city of India, situated at the foot of the Shivalik range of Himalayas in the Northwest India. Coordinates of Chandigarh (North India) are latitude, 30°45′0″N/30.75°, longitude, 76°46′48″E/76.78°, and altitude, 304–365 m above MSL and area of 114 km2. It is bounded on the north and west by Punjab State and on the east and south by Haryana State; therefore, it serves as the capital of these two states, and the triangle of these three cities is collectively called as the Chandigarh Tricity. The surrounding districts are Mohali and Ropar in Punjab and Panchkula in Haryana. Other surrounding areas are Derabassi, Kharar, Lalru, Ambala, Rajpura, and Patiala (all within 70 km range).
Subjects
In the present investigations, the study was conducted on the Chandigarh population. About 950 subjects on the basis of the type of the disease were taken and grouped as normal subjects in Group A (control), patients of diabetes with middle age in Group DM, older diabetics in Group DO, diabetics with osteoarthritis in Group D+OA, osteoarthritis patients in Group OA, and rheumatoid arthritis patients in Group RA matched with number and age (Table 1, except Group Do including older diabetic patients). Mean age and body weights were calculated and measured in each group with duration of the disease (Table 1). Diabetic patients of different mean age subgroups SG-I to IV of Group B and control subjects of different mean age subgroups SG-I to V of control Group A were taken, and the study was done by taking their blood samples (Table 2, only in diabetic patients).
Procurement of Requisite Details of the Subject
The personal and medical history along with relevant details of the subjects were recorded for the present study through a questionnaire. The information required to be filled in the proforma included patients with the type of disease, sex, age, samples taken (blood, urine, hair, and nails), place of residence, occupation, and type of eating habits. Regarding their eating habits, most of them were vegetarians (approximately 80%), and only few were occasional meat eaters (20%) consuming not more than 200 g of fresh chicken or goat meat/week. All of them consumed 250 ml milk/day either full fat milk or skimmed milk. Intake of meat in occasional meat eaters was not significant enough; therefore, the data of vegetarians and occasional meat eaters were pooled for the present investigations. Samples were collected from the Orthopediatric clinic, Sector-16-D, Chandigarh, under the guidance of Dr. H. C. Gupta (Orthopedics and General Surgeon, Former head of the Department of Surgery and Orthopedics, General hospital, Sector-16-D, Chandigarh) and of diabetic patients from Tarun Clinic, Sector-46C, Chandigarh.
Diagnosis of the Disease
Diabetic patients were diagnosed by measuring the serum glucose concentrations (serum glucose > 250 mg/dl). Osteoarthritis patients were taken having the knee osteoarthritis and rheumatoid arthritis patients as having at least three of the following: morning stiffness for more than 45 min, five swollen joints, five tender joints, and erythrocyte sedimentation rate more than 45 mm/h [69].
Sampling of Blood and Urine
The fasting blood samples (10 ml) were taken from each subject from subgroup SG-I to V of control Group A and diabetics from SG-I to V of Group B using a plastic syringe fitted with stainless steel needle (Table 2). The blood was collected into a metal-free plastic tube, allowed to clot, and then centrifuged at 2500 rpm for 15 min. The blood serum was separated and transferred into the metal-free plastic vials. The morning urine samples (spot urine) were collected in the sterilized vials. The samples were collected from each healthy subject and from the diseased subject (from Groups A, DM, DO, D+OA, OA, and RA, Table 1) in the collection vials after every 3 days for three times and stored in the vials (using conc. HNO3). The timing for the spot urine sample was standardized. The blood serum samples were stored in the plastic vials at −20°C and urine samples at 2–4°C for further analysis. However, long storage was avoided in the present study.
Collection of Hair and Nail Samples
For the collection of hair and nail samples, the diseased patients in Groups DM, DO, D+OA, OA, RA, and control subjects in Group A (Table 1) were asked to wash their hands and hairs thoroughly with distilled water and medicated soap (detole) devoid of any metal contamination, followed by drying with clean towel or tissue paper to remove any external contamination. Then, with the help of clean stainless steel scissors, fingernails and hairs from the neck region were collected in the plastic polythene bags.
Washings
The hair and nail samples were scrapped and cut with stainless steel scissors, and both were cleaned of dust particles with nonionic detergent Triton X-100 following the standardized washing procedures [70]. Subsequently, the hair and nail samples were soaked in acetone to remove external contamination, then in alcohol, rinse five times with deionized water, dried in an oven, and stored in desiccators.
Analysis of Mineral Status in Serum, Urine, Hair, and Nails of Control and Diseased Subjects using Atomic Absorption Spectrophotometer
Before subsampling for analysis, the samples of blood serum and urine were shaken vigorously for 1 min to ensure a homogeneous suspension. Samples of blood serum (1 ml), urine (pooled = 1 ml), hair (50 mg), and nails (50 mg) were digested separately in 3:1 nitric acid and perchloric acid in triplicates. The ash formed was dissolved in 6 ml of 10 mM nitric acid and filtered through ash-free filter paper before analysis. They were analyzed for Zn, Cu, Mg, and Mn levels on the atomic absorption spectrophotometer (Electronic Corporation of India Limited, Hyderabad, AAS 4139) using hollow cathode lamps (213.9, 324.8, 285.2, and 279.5 nm for Zn, Cu, Mg, and Mn, respectively) in triplicates with dilutions. Standards for Zn, Cu, Mg, and Mn (Sigma) were prepared in triple distilled deionized water.
Statistical Analysis
The data was subjected to statistical analysis applying Student’s t test and analysis of variance (ANOVA). Results were expressed as mean ± SEM at the significance level p < 0.001 (highly significant), 0.01 (significant), and 0.05 (almost significant) in the tabular form and graphical forms, respectively.
Results
Mineral Concentrations in the Hairs
Hair Zn Concentrations
The data on hair mineral status revealed a highly significant increase and decrease in hair Zn concentrations in the diseased groups than that of control Group A (Table 3). Significant elevations in hair Zn concentrations was evaluated as maximum in Group D+OA, followed by Group DM, and Group OA than that of the control Group A (Table 3, p < 0.001, 0.05). However, a highly significant reduction in hair Zn was recorded in Group RA and Group DO (least concentrations) than that of the control Group A [Table 3, p < 0.001; order of decrease, Group D+OA>DM>OA>A (control)> RA>DO (minimum); Fig. 1a].
Hair Cu Concentrations
The data on hair Cu concentrations shows a highly significant decrease in hair Cu concentrations in all the groups than that of the control Group A (Table 3). Highly significant reductions were evaluated as maximum in Group RA, followed by Group DO, D+OA, OA, and least in Group DM than that of the control Group A [Table 3, p < 0.001; order of decrease, Group A (control)>DM>OA>D+OA>DO>RA (maximum); Fig. 1b].
Hair Mg Concentrations
The status of hair Mg revealed a significant decrease in Mg concentrations in Group DM, followed by Group OA, D+OA, RA, and maximum in Group DO than that of control Group A [Table 3, p < 0.001 and 0.01; order of decrease, Group A (control)>DM>OA>D+OA>RA>DO (maximum); Fig. 1c].
Hair Mn Concentrations
Hair Mn concentrations were also observed to decrease in all the groups than that of control group (Table 3). Highly significant reductions were evaluated as minimum in Group RA, followed by Group OA, D+OA, DM, and maximum in Group DO than that of control Group A [Table 3, p < 0.001; order of decrease, Group A (control)>RA>OA>D+OA>DM>DO (maximum); Fig. 1d].
Mineral Concentrations in the Nails
Nail Zn Concentrations
The status on nail Zn concentrations showed increase and decreases in Zn concentrations. Significant elevations were evaluated as maximum in Group DM, followed by Group D+OA and OA than that of control Group A (Table 4, p < 0.001 and 0.05). Significant reduction in nail Zn concentrations was recorded in Group RA, followed by Group DO (least) than that of control Group A [Table 4, p < 0.001 and 0.05; order of decrease, Group DM>D+OA>OA>A (control)>RA>DO (maximum); Fig. 2a].
Nail Cu Concentrations
A highly significant reductions in nail Cu concentrations were evaluated in all the decreased groups than that of control Group A (Table 4). The reduction in nail Cu was evaluated as minimum in Group OA, followed by Group DM, D+OA, and RA and maximum in Group DO [Table 4, p < 0.001; order of decrease, Group A (control)>OA>DM>D+OA>RA>DO (maximum); Fig. 2b].
Nail Mg Concentrations
A highly significant decrease in nail Mg concentrations were reported in all the diseased groups than that of the control group (Table 4). The reductions were evaluated as minimum in Group OA, followed by DM, DO, and D+OA and maximum in Group RA than that of control Group A [Table 4, p < 0.001; order of decrease, Group A (control)>RA>DM>DO>D+OA>RA (maximum); Fig. 2c].
Nail Mn Concentrations
Highly significant reduction in nail Mn concentrations were reported in all the groups than that of control group (Table 4). The reductions were evaluated as minimum in Group RA, followed by Group OA, D+OA, and DM and maximum in Group DO [Table 4, p < 0.001; order of decrease, Group A (control)>RA>OA>D+OA>DM>DO (maximum); Fig. 2d].
Mineral Levels in the Urine
Urine Zn Levels
Both the elevation and reductions in urine Zn levels was reported in all the diseased groups than that of control group (Table 5). Highly significant elevations in urine Zn were evaluated as maximum in Group DO, followed by Group DM and D+OA than that of the control Group A (Table 5, p < 0.001). But a significant and non-significant reductions were evaluated in Groups OA and RA than that of control Group A (Table 5, p < 0.01; order of decrease, Group DO>DM>D +OA>A (control)>RA>OA (least); Fig. 3a].
Urine Cu Levels
Highly significant elevations in urine Cu levels were reported in all the diseased groups than that of the control group (Table 5). The elevations in urine Cu was evaluated as maximum in Group RA, followed by Groups D+OA, DO, and OA and least in Group DM than that of control Group A [Table 5, p < 0.001; order of decrease, Group RA>D+OA>DO>OA>DM>A (control); Fig. 3b].
Urine Mg Levels
Highly significant elevations in urine Mg levels were reported in all the diseased groups than that of control group (Table 5). The elevations were evaluated as maximum in Group RA, followed by Groups OA, D+OA, and DO and least in Group DM than that of control Group A [Table 5, p < 0.001; order of decrease, Group RA>OA>D+OA>DO>DM>A (control); Fig. 3c].
Urine Mn Levels
Urine Mn levels were also reported to increase significantly in all the diseased groups than that of control group (Table 5). The elevations in urine Mn levels was evaluated as maximum in Group DO, followed by Group DM, OA, and D+OA and least in Group RA than that of control Group A [Table 5, p < 0.001; order of decrease, Group DO>DM>OA>D+OA>RA>A (control); Fig. 3d].
Mineral Status in the Serum of Diabetic Patients
Serum Zn, Cu, Mg, and Mn Levels
A highly significant rise in serum Zn, Cu, Mg, and Mn concentrations were evaluated in the diabetics with subgroup from SG-I to IV in Group B than their control counterparts as SG-I to IV in control Group A (Table 6). The elevations were evaluated as values rising from SG-I to IV of Group B diabetic patients, and thereafter, the concentrations decreased in SG-V but still were high than control SG-V in Group A control, respectively (Table 6, p < 0.001, 0.01, and 0.05).
Discussion
The data showed a highly significant rise of Zn concentrations in hair and nails of Group DM (middle aged diabetics) and Group D+OA (diabetics with osteoarthritis) patients, followed by Group OA (osteoarthritis), but a significant decrease in Zn concentrations was observed in Group DO (older diabetics) and Group RA patients (rheumatoid arthritis) than that of control Group A (Tables 3 and 4; Figs. 1a and 2a). The more rise in hair and nail Zn levels in Group DM (middle-aged diabetics) and Group D+OA (diabetics with osteoarthritis) was observed, as they are genetically predisposed to absorption and retention of more Zn in the body [71].
These results are significant in terms of Chandigarh population who are predominantly vegetarian. The recent survey on trace metal status of different vegetables in State of Punjab around Chandigarh revealed that the concentrations of Cu and Mg are within prescribed limit, but that of Zn concentration is significantly higher (40 mg/kg or more in above ground vegetables and 120 mg/kg or above in underground vegetables) in underground-water-irrigated vegetables. The reason for its higher concentration in vegetables has been linked to different inputs used in the fields by farmers during the growth of vegetables [20]. Recent data on Zn levels estimated in cereals and other food stuffs was also found to be high. The higher level of Zn in tissues of overweight and obese women than those with body mass index of 25 kg/m2 observed in Indians, more so in Punjabis [62, 63], is on account of high Zn in food [72] due to the liberal use of Zn as ZnSO4 as a micronutrient in agricultural practices employed by the farmers and the low amount of Zn-binding factor such as phytates and fibers in their diet. It is further supported by epidemiological studies where in spite of hyperzincuria, the diabetic patients have not appeared to be Zn deficient [73]. This is further evident by elevated Zn concentration in serum, urine, and mononuclear cell in diabetic patients after high dose Zn supplementation, which has a greater ramification in diabetes [71]. The concentration of metals in blood plasma at a given time represents a total of bound, exchangeable, and catabolic components of metals. They, therefore, lead to confusing results and predictions, more so in case of chronic diseases where urinary losses are high. The metal concentrations in tissues are more dependable indicator of assessing metal deficiencies/excesses, as their concentrations are maintained through dynamic equilibrium between tissue metals and exchangeable metal components of the blood plasma. The metals concentrations in tissues therefore were estimated in the present investigations as better indicators of mineral status in the body than that of blood plasma.
The loss of glucose in urine and hyperzincuria increased with increase in time duration and amount of Zn present in diet. Urinary Zn excretion has also been correlated with the degree of either glucosuria [45, 74] or albuminuria [75, 76]. Cunningham et al. reported that increased Zn mass action increases more Zn levels in the body and urine of both diabetic and normal individuals that coincided well with the present investigations as more increased Zn concentrations were evaluated in the urine of diabetic patients and even with osteoarthritis (Table 4; Fig. 3a), which may have link to increased Zn intake through food stuffs in this region (Chandigarh population), as increased Zn concentrations were observed in the vegetables consumed by this population [20]. Chausmer [42] has postulated that hyperglycemia interferes with the active transport of Zn back into the renal tubular cell and results in hyperzincuria. Further, previous studies have also suggested elevated excretions of Zn in urine of diabetic patients as observed in the present investigations [43, 45].
Cu concentrations in the hair and nails were evaluated to decrease significantly in all the groups than that of control Group A (Tables 3 and 4; Figs. 1b and 2b). Similarly, Mg and Mn concentrations in hair and nails were also reduced significantly in all the groups than that of control Group A (Tables 3 and 4; Figs. 1c,d and 2c,d). Use of excessive Zn in free-living population has been discouraged because it results in Cu-deficiency. Zn and Cu are essential elements that exhibit important interactions and possibly inhibition of each other’s transport and bioavailability [77]. The excess Zn in the vegetable food stuffs (vegetarians) and meat food stuffs (non-vegetarians) consumed by the population in this region made them Cu deficient, as decreased Cu concentrations in hair and nails were observed in the all the diseased groups in the present investigations [65–68]. Further, increased Zn concentrations in the hair and nails in Group DM (middle-aged diabetics) and Group D+OA (diabetics with osteoarthritis) also coincide well with respect to their increased body weights (Tables 1, 3, 4; Figs. 1a and 2a) because it is already reported in ours and other previous epidemiological studies where a positive relationship between Zn concentrations in hair with obesity, diabetics, and myocardial infarction but an inverse correlation with copper concentrations in hard tissues, such as hair and nails, were observed that support the present findings [21, 62–64].
Increase and decrease in hair and nail Zn levels in Groups OA and RA patients were reported due to the involvement of more cytokines, as RA is a chronic inflammatory disease. Higher serum IL1, IL-6, and TNFα were found to be elevated in RA patients [78] and is involved in the alteration of trace metals metabolism. Synthesis of metallothioneins was observed to be induced by IL-1 in the liver that causes marked accumulation of Zn in the liver and inflamed joints [79], and consequently, due to more inflammatory action in RA, more reduction in hair and nails Zn concentrations were evaluated in Group RA than OA (Tables 3, 4; Figs. 1a and 2a). Secondly, osteoarthritis patients in Group OA were having more body weight than the rheumatoid arthritis patients in Group RA, which may cause more Zn concentrations in the hair and nails of Group OA (Tables 2, 3, 4; Figs. 1a and 2a) than Group RA patients [21].
Highly significant elevation in urinary Cu concentrations in Group RA (rheumatoid arthritis) than Group OA (osteoarthritis), even larger than Group DM (middle aged diabetics), Group DO (older diabetics), and Group D+OA (diabetics with osteoarthritis) further explained the effect of acute chronic inflammatory process hypothesized to increase the body requirement for Cu [59, 80]. The non-significant decrease in urinary Zn levels in Group RA (rheumatoid arthritis) in the present investigations are again in accordance with previous finding [59] but with a significant decrease in Group OA patients (osteoarthritis). Further, more reduction in hair and nails Cu in rheumatoid arthritis patients in Group RA suggests severe Cu deficiency in RA than OA (Tables 3 and 4; Figs. 1b and 2b). Increased urinary Cu excretions in RA observed in previous studies may be due to increased plasma Cu concentrations in RA than OA and control, leading to more excretions in the urine [81]. Secondly, Zn depressed Cu absorption even if the intake was in normal physiological ranges, a study done in the patients of rheumatoid arthritis previously [82]. Zn-rich diet consumed in this region may depress the Cu absorption resulting in Cu deficiencies as observed in all the groups than that of control Group A. Urinary Cu levels further increased in the patients of diabetics with osteoarthritis in Group D+OA, but values were observed to be still less than the Group RA patients (rheumatoid arthritis) showing the significance of more inflammatory response on trace metal status in rheumatoid arthritis as compared to other groups (Tables 2, 3, 4; Fig. 3b). Decrease in Zn concentrations in nail and hair of rheumatoid arthritis patients in Group RA shows a redistribution of trace elements due to inflammatory character [83].
The concentration of antioxidant enzymes in the liver to eliminate free radicals is very important. Cu, Zn, and Mn are the key components of the major antioxidants, i.e., superoxide dismutase enzymes (SOD), which have been shown to fight against the reactive oxygen intermediates that are linked to joint damages in arthritis [11]. Mitochondrial manganese superoxide dismutase (Mn-SOD) is the primary cellular defense against damaging superoxide radicals generated by aerobic metabolism. As in inflammatory diseases, its elevated levels were observed to provide protection against arthritic inflammation. This may be the reason for the elevation in Mn concentrations in hair and nails of Group RA (rheumatoid arthritis) patients as compared to other diseased groups but were less than the control Group A (Tables 3 and 4; Figs. 1d and 2d) and well coincide with its less urinary excretions in Group RA (less excretion) than the other groups [84] but still larger than control Group A (Table 5; Fig. 3d).
Mg in the body is primarily located in bone and cartilage [85], and up to a third of Mg in the body is intracellular [86]. It is suggested that decreased Mg concentrations observed in the present investigations in all the diseased groups especially in arthritis conditions (Tables 3, 4; Figs. 1c and 2c) may impair the expression and activity of the receptors causing cell damage, cell death, and ECM degeneration, which may ultimately lead to cartilage damage and joint lesions [87].
Low level of Cu in hair and nails of rheumatoid arthritis patients in Group RA may be due to low plasma total antioxidant capacity than Group OA patients (OA) suggesting more inflammatory character in RA, as severely decreased SOD activities were observed in RA than OA in the previous study [88]. It also suggests a more dietary Cu requirement to maintain hepatic Cu–Zn SOD activity [89] in RA than OA. The findings of previous study suggest that cumulative oxidative stress leads to a decreased antioxidant capacity in articular cartilage resulting in chondrocyte genomic instability especially telomere shortening, regardless of cell proliferation [90] linking overproduction of ROS to acute inflammatory response [91–93]. Cu status could affect bone breakdown in young adult women via at least two mechanisms: firstly, lysyl oxidase activity, a Cu enzyme that cross-links collagen, involved in bone structure, and secondly, superoxide dismutase activity that eliminates superoxide radicals stimulating bone resorption. It was confirmed in young adult women who were screened for Cu status based on erythrocyte superoxide dismutase activity. In women with Cu/Zn SOD activities<65% values, when supplemented with Cu (2 mg/day as copper glycine amino acid chelate, Albion) or a placebo for 6 weeks, the Cu but not the placebo raised superoxide dismutase activities and urinary ratio of collagen cross-links to collagen protein. Similarly, manganese glycine amino acid chelate supplementation led to significant increase in MnSOD activity, which showed increased requirement of Cu and Mn in arthritic conditions [94]. Lysyl oxidase enzyme is required for the inflammations of pyrodoline cross-links between collagen fibrils. It was suggested that Cu deficiency via inadequate lysyl oxidase leads to poorly cross-linked and weakened cartilage susceptible to subsequent fragmentation. Cu is reported to have anti-arthritic effects [95, 96]. Studies in 1996 demonstrated the stimulatory effects of Cu supplementation to chondrocytes in vitro on proteoglycan synthesis and abrogation of proteoglycan depletion after exposure to inflammatory synovium [97, 98].
Further, when Group DM (middle-aged diabetics) and Group D+OA (diabetics with osteoarthritis) were compared, more Zn and Mn concentrations were observed with less Cu and Mg concentrations in Group D+OA (diabetics with osteoarthritis) than Group DM (middle-aged diabetics) with respect to control Group A (Tables 3, 4; Figs. 1a,d and 2a,d). Less urinary Zn and Mn, but more Cu and Mg levels were observed in Group D+OA patients (diabetics with osteoarthritis) than Group DM (middle aged diabetics) with respect to control Group A (Table 5; Fig. 3a,d). This alteration may be associated with more degenerative conditions in cartilage, such as in osteoarthritis (OA), that occur after coincidently with metabolic dysfunction, nutrient imbalance, and diabetes mellitus [99–101]. Clinical and epidemiological survey of OA patients with diabetes mellitus supports the hypothesis that hyperglycemia affects matrix macromolecules and may be related to the development of degenerative joint and bone diseases [102] and may be the possible reason for the increase in Zn and Mn concentrations and reduction in Cu and Mg levels in hair and nails of Group D+OA (diabetics with osteoarthritis) than Group DM patients (middle-aged diabetics) with respect to control Group A (Tables 2, 3, and 4; Figs. 1a–d and 2a–d).
Lastly, the mineral status in older diabetic patients showed a significant reduction in Zn, Cu, Mg, and Mn in hair and nails of Group DO (older diabetics) compared to other groups and with respect to control Group A (Tables 3 and 4; Figs. 1a–d and 2a–d). It was coincided well with their higher increase in urine Zn, Mn, Cu, and Mg levels than the other groups and control Group A (Table 5; Figs. 3a–d). Urinary Zn excretion has been reported to correlate with the degree of glucosuria [45, 74]. These studies suggest that hyperzincuria is a component of pathology of IDDM. Hyperzincuria of IDDM was accompanied by measurements of plasma Zn that was elevated [45, 71, 74, 76, 103–107]. Earlier works have also demonstrated elevated serum Cu [108] and an unexplained hyperzincuria in this metabolic disease [46]. It revealed that diabetic conditions in old age becomes more damaging and leads to more deficiency of Zn and Mn, followed by Cu and Mg in Group DO than the diabetes during middle age in Group DM patients. It was further confirmed by measuring the serum mineral status in diabetic patients, which further revealed a highly significant rise in serum Zn, Cu, Mg, and Mn levels from SG-I to IV in Group B except SG-V (older diabetics) where a reduction in serum mineral status was recorded as compared to other diabetic patients in Group B that showed less mineral concentrations in the body of older diabetic patients as observed in Group DO than the middle aged diabetics in Group DM, respectively (Tables 5 and 6; Figs. 1a–d and 2a–d).
Conclusion
Although obesity, NIDDM, IDDM, osteoarthritis, and rheumatoid arthritis are considered to be the genetic disorder, their patients appear to have genetic predisposition of excessive absorption and retention of Zn in their tissues. Excessive bioavailability of Zn in the food chain exacerbates its deposition causing leaching of other physiologically important elements, including Cu, Mn, and Mg, from their tissues in spite of their adequate concentrations in food items. For Cu, Mn, and Mg, being components of enzymes involved in antioxidant defense system, there deficiencies at young age due to excessive Zn in diet lead to an early onset of pro-inflammatory response resulting their early onset, relatively at a younger age, which appears to be the possible cause for these obesity-related diseases in the population of the Chandigarh.
References
Grundy SM, Brewer HB, Cleeman JI, Smith SC, Lenfant C (2004) Definition of metabolic syndrome. Circulation 109:433–438
Goodman E, Dolan LM, Morrison JA, Daniels SR (2005) Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation 111:1970–1977
Colditz GA, Willett WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, Speizer FE (1990) Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 132:501–513
MacMohn S, Rimm EB, Willett WC (1987) Obesity and hypertension epidemiological and clinical issues. Eur Heart J 8:57–70
Fung TT, Rimm EB, Spiegelman D, Rifai N, Tofler GH, Willett WC, Hu FB (2001) Association between dietary patterns and plasma biomarkers of obesity and cardiovascular disease risk. Am J Clin Nutr 73:61–67
Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM (2002) Relationship between obesity, insulin resistance and coronary heart disease risk. J Am Coll Cardiol 40:937–943
Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285:2486–2497
Felson DT (1995) Weight and osteoarthritis. J Rheumatol Suppl 43:7–9
Felson DT (1996) Weight and osteoarthritis. Am J Clin Nutr 63:430S–432S
Cicuttini FM, Spector T, Baker J (1997) Risk factors for osteoarthritis in the tibiofemoral and patellofemoral joints of the knee. J Rheumatol 24:1164–1167
Mezzetti I, Grigolo B, Pulsatelli L, Dolzani P, Silvestre T, Roseta L, Meliconi R, Facchini A (2001) Differential roles of nitric oxide and oxygen radicals in chondrocytes affected by osteoarthritis and rheumatoid arthritis. Clin Sci 101:593–599
Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM (1995) Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J Clin Invest 95:2409–2415
Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB (1995) The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss and relationship to lipoprotein lipase. J Clin Invest 95:2111–2119
Saghizadeh M, Ong JM, Garvey WT, Henry RR, Kern PA (1996) The expression of TNF alpha by human muscle. Relationship to insulin resistance. J Clin Invest 97:1111–1116
Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host (review). J Lipid Res 45(7):1169–1196
Lin HC, Wan FJ, Wu CC, Tung CS, Wu TH (2005) Hyperbaric oxygen protects against lipopolysaccharide-stimulated oxidative stress and mortality in rats. Eur J Pharmacol 508:249–254
Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima O (2004) Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114(12):1752–1761
Wellen KE, Hotamisiligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115:1111–1119
Swami HM, Bhatia V, Gupta AK, Bhatia SPS (2005) An epidemiological study of obesity among elderly in Chandigarh. Indian J Community Med 30:1–8
Ram B, Garg SP, Matharu SS (2005) Effect of contaminants in wastewater on soil and vegetables—a case study. Panjab Pollution Control Board, Panjab
Taneja SK, Mahajan M (1999) Zinc in obesity—a critical review. J Punjab Acad Sci 1:211–216
Kang R (1997) Effect of varying concentrations of zinc in high fat diet on fats accumulating tissues of mice, M. Sc. Thesis, Panjab University, Chandigarh, India
Pomp D, Oberbauer AM, Murray JD (1992) Growth and body composition of OMT-la-OGH transgenic male mice with differing periods of transgene activation. J Anim Sci 70(1):198–201
Pomp D, Oberbauer AM, Murray JD (1996) Development of obesity following inactivation of a growth transgene in mice. Transgenic Res 5:13–23
Prentice A (1993) Does mild zinc deficiency contribute to poor growth performance? Nutr Rev 5:268–270
Collipp PJ (1984) New developments in medical theory of obesity, thyroid and zinc. Pediatrics Ann 13:465–472
Begin-Heick N, Daple-Scott M, Rowe J, Heick HMC (1985) Zinc supplementation attenuates insulin secretory activity in pancreatic islets of the ob/ob Mouse. Diabetes 34:179–184
Taneja SK, Mandal R, Girhotra S (2006) Long term excessive Zn-supplementation promotes metabolic syndrome-X in Wistar rats fed sucrose and fat rich semi synthetic diet. Indian J Exp Biol 44:705–718
Klein S, Coppack SW, Mohamed-Ali V, Landt M (1996) Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45:984–987
Suter PM, Locher R, Hasler E, Vetter W (1998) Is there a role for the ob gene product leptin in essential hypertension? Am J Hypertens 11:1305–1311
Ahima RS, Flier JS (2000) Leptin. Annu Rev Physiol 62:413–437
Chen MD, Lin PY (2000) Zinc-induced hyperleptinemia relates to the amelioration of sucrose-induced obesity with zinc repletion. Obes Res 8:525–529
Sandoval DA, Davis SN (2003) Leptin metabolic control and regulation. J Diabetes its Complicat 17:108–113
Veniant MM, LeBel CP (2003) Leptin: from animals to humans. Curr Pharm Des 9:811–818
Baltaci AD, Mogulkoc R, Halifeoglu I (2005) Effects of zinc deficiency and supplementation on plasma leptin levels in rats. Biol Trace Elem Res 104:41–46
McArdle HJ, Erlich R (1991) Copper intake and transfer to the mouse fetus during pregnancy. J Nutr 121:208–214
Graham TW, Thurmond MC, Mohr FC, Holmberg CA, Anderson ML, Keen CL (1994) Relationship between maternal and fetal liver copper, manganese and zinc concentrations and fetal development in California, Holstein dairy cows. J Vet Diag Invest 6:77–87
Christian P, Khatry SK, Leclerq SC, Pradhan EK, Clemens GD, Clemens SR, Katz J, West KP (2001) Effect of prenatal multiple micronutrient supplementations on low birth weight and 6-month mortality among infants in rural Nepal: a double-masked, randomized community trial. Ann Nutr Metab 45:463 (Abstract)
Nicoloff G, Mutaftchie VK, Strashimirov D, Petrova C (2004) Serum manganese in children with diabetes mellitus type 1. Diabetol Croat 33(2):47–51
Strain JJ (1991) Disturbances of micronutrient of antioxidant status in diabetes. Proc Nutr Soc 50:591–604
Mooradian AD, Failla M, Hoogwerf B, Maryniuk M, Wylie-Roset J (1994) Selected vitamins and minerals in diabetes. Diabetes Care 5:464–478
Chausmer AB (1998) Zinc, insulin and diabetes. J Am Coll Nutr 17:109–115
Mateo MCM, Bustamante JB, Dequiros JFB, Manchado OO (1975) A study of the catabolism of zinc, its metalloenzymes in diabetes mellitus. Biomedicine 23:134–136
Mateo MCM, Bustamante JB, Cantalapiedra MAG (1978) Serum zinc, copper and insulin in diabetes mellitus. Biomedicine 29:56–58
McNair P, Kiilerich S, Christiansen C, Christiansen MS, Madsbad S, Transbol I (1981) Hyperzinuria in insulin treated diabetes mellitus—its relation to glucose homeostasis and insulin administration. Clin Chem Acta 112:343–348
Pidduck HG, Wren PJJ, Price-Evans DA (1970) Hyperzincuria of diabetes mellitus and possible genetical implications of these observations. Diabetes 19:240–247
Kumar S, Rao KSJ (1974) Blood and urinary zinc levels in diabetes mellitus. Proc Nutr Soc 38:106A–112A
Tarui S (1963) Studies on zinc metabolism-III. Effect of the diabetic state on zinc metabolism: a clinical aspect. Endocrinol Jap 10:9–15
Davies IJT, Musa M, Dormandy TL (1968) Measurements of plasma zinc. I. In health and disease, II. In malignant disease. J Clin Pathol 21:359–365
Rosner F, Gorfien PC (1968) Erythrocyte and plasma zinc and magnesium levels in health and disease. J Lab Clin Med 72:213–219
Pidduck HG, Wren PJ, Evans DAP (1970a) Plasma zinc and copper in diabetes mellitus. Diabetes 19:234–239
Constan GR, Leeman W, Almasy F, Constan AG (1964) Weitere beabachtungen uber din zink-stoggwechesel bei diabetes mellitus. Schweiz Med Wochenschr 94:1104–1111
Chooi MK, Todd JK, Boyd ND (1976) Influence of age and sex on plasma zinc levels in normal and diabetic individuals. Nutr Metab 20:135–142
Starcher BC, Hill CH, Madaras JG (1980) Effect of zinc deficiency on bone collagenase and collagen turnover. J Nutr 110:2095–2102
Lappalainen R, Knuuttila M, Lammi S, Alhava EM, Olkkonen H (1982) Zn and Cu content in human cancellous bone. Acta Orthop Scand 53:51–55
Fraker PJ, Jardieu P, Cood J (1987) Zinc deficiency and immune function. Arch Dermatol 123:1699–1701
Stabel JR, Spears JW (1989) Effect of copper on immune function and disease resistance. Adv Exp Med Biol 258:243–252
Milanino R, Frigo A, Bambara LM, Marrella M, Moretti M, Pasqualicchio M, Biasi D (1993) Copper and zinc status in rheumatoid arthritis: studies on plasma, erythrocytes and urine, and their relationship with disease activity markers and pharmacological treatment. Clin Exp Rheumatol 11:271–281
Aaseth J, Munthe E, Forre O, Steinnes E (1978) Trace elements in serum and urine of patients with rheumatoid arthritis. Scand J Rheumatol 7(4):237–240
Dore-Duffy P, Peterson M, Catalanotto F, Marlow S, Ho SY, Ostrom M, Weinstein A (1990) Zinc profiles in rheumatoid arthritis. Clin Exp Rheumatol 8(6):541–546
Taysi S, Gulcin I, Sari RA, Kuskay S, Bakan N (2003) Trace elements and disease activity score in patients with rheumatoid arthritis. Pain Clin 15(4):435–439
Taneja SK, Mahajan M, Arya P (1996) Excess bioavailability of zinc may cause obesity in humans. Experientia 52:31–33
Taneja SK, Mahajan M, Gupta S, Singh KP (1998) Assessment of copper and zinc status of hair and urine of young women descendant of NIDDM parents. Biol Trace Elem Res 62:255–264
Sukumar A, Subramanian R (1992) Elements in hair and nails of urban residents of New Delhi: CHD, hypertension and diabetic cases. Biol Trace Elem Res 34:89–98
Patterson WP, Winkelmann M, Perry MC (1985) Zinc-induced copper deficiency: mega-mineral sideroblastic anemia. Ann Intern Med 103(3):385–386
Yadrich MK, Kenney MA, Winterfeldt EA (1989) Iron, copper and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr 49:145–150
Sandstead HH (1995) Requirements and toxicity of essential trace elements, illustrated by zinc and copper. Am J Clin Nutr 61:621S–624S
Groff JL, Gropper SS (2000) Advanced nutrition and human metabolism. Wadsworth/Thompson Learning, Belmont, p 419
Wanchu A, Deodhar SD, Sharma M, Gupta V, Bambery P, Sud A (1997) Elevated levels of antiproteus antibodies in patients with active rheumatoid arthritis. Indian J Med Res 105:39–42
Gammelgaard B, Peters K, Menno T (1991) Reference values for the nickel concentrations in human fingernails. J Trace Elem Electrol Health Dis 5:121–123
Cunningham JJ, Fu A, Mearkte PL, Brown RG (1994) Hyperzincuria in individuals with insulin-dependent diabetes mellitus: concurrent zinc status and the effect of high-dose zinc supplementation. Metabolism 43(12):1558–1562
Agte V, Chiplonkar S, Joshi N, Paknikar K (1994) Apparent absorption of copper and zinc from composite vegetarian diet in young Indian men. Ann Nutr Metabol 38(1):13–19
Ekmekcioglu C, Prohaska C, Pomazal IS, Schernthaner G, Marktl W (2001) Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls. Biol Trace Elem Res 79:205–219
Canfield WK, Hambrige KM, Johnson LK (1984) Zn nutrition in type-I diabetes mellitus: relationship to growth measures and metabolic control. J Pediatr Gastroenterol Nutr 3:577–584
Brun JF, Moynier I, Orsetti A (1988) Increased Zn urinary excretion in type-I diabetic patients with excessive microalbuminuria. Horm Metabo Res 20:307–309
Heise CC, King JC, Costa FM (1988) Hyperzincuria in IDDM women: relationship to measures of glycemic control, renal function and tissue catabolism. Diabetes Care 11:780–786
Hurley LS, Keen CL, Lonnerdal B (1983) Aspects of trace element interactions during development. Fed Proc 42:1735–1739
Altomonte L, Zoli A, Mirone L, Scolieri P, Magaro M (1992) Serum levels of interleukin 1β, tumor necrosis factor α and interleukin 2 in rheumatoid arthritis, correlation with diseases activity. Clin Rheumatol 11:202–205
Zoli A, Altomonte L, Caricchio R, Galossi A, Mirone L, Ruffini MP, Magaro M (1998) Serum zinc and copper in active rheumatoid arthritis: correlation with interleukin 1β and tumors necrosis factor α. Clin Rheumatol 17:378–382
DiSilvestro RA, Marken JT, Skehan M (1992) Effects of copper supplementation on ceruloplasmin and copper-zinc superoxide dismutase in free-living rheumatoid arthritis patients. J Am Coll Nutr 11(2):177–180
Yazar M, Sarban S, Kocyigit A, Isikan UE (2005) Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis. Biol Trace Elem Res 106(2):123–132
Honkanen VE, Lamberg-Allardt CH, Vesterinen MK, Lehto JH, Westermarch TW, Metsa-Ketela TK (1991) Plasma zinc and copper concentrations in rheumatoid arthritis: influence of dietary factors and disease activity. Am J Clin Nutr 54:1082–1086
Wanchu A, Sud A, Bambery P, Prasad R, Kumar V (2002) Plasma and peripheral blood mononuclear cells levels of Zn and Cu among Indian patients with RA. Ann Rheum Dis 61:88–85
Hallgren R, Svenson K, Johansson E, Lindh U (1985) Elevated granulocyte manganese in rheumatoid arthritis and other connective tissue diseases. J Rheumatol 12(5):876–880
Schaafsma A, deVries PJF, Saris WHM (2001) Delay of natural bone loss by higher intakes of specific minerals and vitamins. Crit Rev Food Sci Nutr 41:225–249
Rude RK, Olerich M (1996) Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy. Osteoporos Int 6:453–461
Stahlmann R, Forster C, Shakibaei M, Flores J, Vormann J, Gunther T, Merker HJ (1995) Magnesium deficiency induces joint cartilage lesions in juvenile rats which are identical to quinolone-induced arthropathy. Antimicrob Agents Chemother 39:2013–2018
Sarban S, Kocyigit A, Yazar M, Isikan UE (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38(11):981–986
DiSilvestro RA, Marken JT (1990) Effects of inflammation and copper intake on rat liver and erythrocyte Cu-Zn superoxide dismutase activity levels. J Nutr 120(10):1223–1227
Yodoh K, Trieu NV, Nakamura H, Hongo-Masuko K, Kato T, Nishioka K (2005) Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and down regulation of chondrocyte function. Arthritis Res Ther 7:R380–R391
Tan DX, Manchester LC, Reiter RJ, Qi W, Karbownik M, Calvo JR (2000) Significance of melatonin in antioxidative defense system: reactions and products. Biol Signals Recept 9:137–159
Reiter RJ (2000) Melatonin: lowering the high price of free radicals. News Physiol Sci 15:246–250
Reiter RJ, Tan DX, Acuna-Castroviejo D, Burkhardt S, Karbownik M (2000) Melatonin: mechanisms and actions as an antioxidant. Curr Topics Biophys 24:71–183
Davis CD, Greger JL (1992) Longitudinal changes of manganese-dependent superoxide dismutase and other indexes of manganese and iron status in women. Am J Clin Nutr 55:747–752
Rosenstein ED, Caldwell JR (1999) Trace elements in the treatment of rheumatic conditions. Rheum Dis Clin North Am 25:929d–935d
Caldwell JR (1999) Venoms, copper and zinc in the treatment of arthritis. Rheum Dis Clin. North Am 25:919–928
Pasqualicchio M, Gasperini R, Velo GP, Davies ME (1996) Effects of copper and zinc on proteoglycan metabolism in articular cartilage. Mediators Inflam 5:95–99
Davies ME, Pasqualicchio M, Henson F, Hernandez VG (1996) Effects of copper and zinc on chondrocyte behavior and matrix turnover. Pferfeheikunde 12:367–370
Rosenbloom AL, Silverstein JH (1996) Connective tissue and joint disease in diabetes mellitus. Endrocrinol Metab Clin North Am 25:473–483
Denko CW, Malemud CJ (1999) Metabolic disturbances and synovial joint responses in osteoarthritis. Front Biosci 4:D686–D693
Okma-Keulen P, Hopman-Rock M (2001) The onset of generalized osteoarthritis in older women: a qualitative approach. Arthritis Rheum 45:183–190
Cimmino MA, Cutulo M (1997) Plasma glucose concentration in symptomatic osteoarthritis: a clinical and epidemiological survey. Clin Exp Rheumatol 24:1164–1167
Kinlaw WB, Levine AS, Morley JE, Silvis SE, McClain CJ (1983) Abnormal zinc metabolism in type-II diabetes mellitus. Am J Med 75:273–277
Levine AS, McClain CJ, Handwerger BS, Brown DM, Morley JE (1983) Tissue zinc status of genetically diabetic and streptozotocin-induced mice. Am J Clin Nutr 37:382–386
Sjogren A, Edvinsson L, Floren CH, Abdulla M (1986) Zinc and copper in striated muscle and body fluids from subjects with diabetes mellitus type I. Nutr Res 6:147–154
Raz I, Havivi E (1989) Trace elements in blood cells of diabetic subjects. Diabetes Res 10:21–24
Chen MD, Lin PY, Tsou CT, Wang JJ, Lin WH (1995) Selected metals status in patients with non-insulin dependent diabetes mellitus. Biol Trace Res 50:119–124
Sinha SN, Gabrieli ER (1970) Serum copper and zinc in various pathological conditions. Am J Clin Pathol 54:570–577
Acknowledgements
Thanks are due to Prof. T. Gill for laboratory facilities. Financial assistance of Panjab University, Chandigarh to R. Mandal is gratefully acknowledged, and thanks are due to Dr. H.C. Gupta from Orthpediatric clinic, Sector-16-D, Chandigarh (Orthopedics and General Surgeon, former head of Department of Surgery and Orthopedics, General hospital, Sector-16-D, Chandigarh) and Mr. K. L. Kapur (Tarun Clinic, Sector-46C, Chandigarh) for providing the samples.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taneja, S.K., Mandal, R. Assessment of Minerals in Obesity-related Diseases in the Chandigarh (India) Population. Biol Trace Elem Res 121, 106–123 (2008). https://doi.org/10.1007/s12011-007-8035-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-007-8035-1